{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T05:28:14Z","timestamp":1785821294838,"version":"3.56.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2014,5,15]],"date-time":"2014-05-15T00:00:00Z","timestamp":1400112000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Apoptosis"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1007\/s10495-014-0997-9","type":"journal-article","created":{"date-parts":[[2014,5,14]],"date-time":"2014-05-14T12:24:03Z","timestamp":1400070243000},"page":"1281-1292","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["H2AX phosphorylation regulated by p38 is involved in Bim expression and apoptosis in chronic myelogenous leukemia cells induced by imatinib"],"prefix":"10.1007","volume":"19","author":[{"given":"Yaqiong","family":"Dong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianning","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ze","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianhui","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinpin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengshan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengrong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,5,15]]},"reference":[{"key":"997_CR1","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1056\/NEJM200104053441409","volume":"344","author":"JM Goldman","year":"2001","unstructured":"Goldman JM, Melo JV (2001) Targeting the BCR-ABL tyrosine kinase in chronic myeloid leukemia. N Engl J Med 344:1084\u20131086","journal-title":"N Engl J Med"},{"key":"997_CR2","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMra020777","volume":"349","author":"JM Goldman","year":"2003","unstructured":"Goldman JM, Melo JV (2003) Chronic myeloid leukemia\u2013advances in biology and new approaches to treatment. N Engl J Med 349:1451\u20131464","journal-title":"N Engl J Med"},{"key":"997_CR3","doi-asserted-by":"crossref","first-page":"5489","DOI":"10.1158\/0008-5472.CAN-07-0302","volume":"67","author":"KM Brauer","year":"2007","unstructured":"Brauer KM, Werth D, von Schwarzenberg K, Bringmann A, Kanz L, Grunebach F (2007) BCR-ABL activity is critical for the immunogenicity of chronic myelogenous leukemia cells. Cancer Res 67:5489\u20135497","journal-title":"Cancer Res"},{"key":"997_CR4","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/aps.2012.9","volume":"33","author":"YJ Zhang","year":"2013","unstructured":"Zhang YJ, Lu CR, Cao Y, Luo Y, Bao RF, Yan S et al (2013) Imatinib induces H2AX phosphorylation and apoptosis in chronic myelogenous leukemia cells in vitro via caspase-3\/Mst1 pathway. Acta Pharmacol Sin 33:551\u2013557","journal-title":"Acta Pharmacol Sin"},{"key":"997_CR5","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.3109\/10428190903147637","volume":"50","author":"D Dumka","year":"2009","unstructured":"Dumka D, Puri P, Carayol N, Lumby C, Balachandran H, Schuster K et al (2009) Activation of the p38 Map kinase pathway is essential for the antileukemic effects of dasatinib. Leuk Lymphoma 50:2017\u20132029","journal-title":"Leuk Lymphoma"},{"key":"997_CR6","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ccr.2009.08.012","volume":"16","author":"MP Strout","year":"2009","unstructured":"Strout MP, Schatz DG (2009) Imatinib resistance and progression of CML to blast crisis: somatic hypermutation AIDing the way. Cancer Cell 16:174\u2013176","journal-title":"Cancer Cell"},{"key":"997_CR7","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/1476-4598-9-112","volume":"9","author":"Z Lu","year":"2010","unstructured":"Lu Z, Jin Y, Chen C, Li J, Cao Q, Pan J (2010) Pristimerin induces apoptosis in imatinib-resistant chronic myelogenous leukemia cells harboring T315I mutation by blocking NF-kappaB signaling and depleting Bcr-Abl. Mol Cancer 9:112","journal-title":"Mol Cancer"},{"key":"997_CR8","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.ccr.2009.07.030","volume":"16","author":"L Klemm","year":"2009","unstructured":"Klemm L, Duy C, Iacobucci I, Kuchen S, von LG, Feldhahn N et al (2009) The B cell mutator AID promotes B lymphoid blast crisis and drug resistance in chronic myeloid leukemia. Cancer Cell 16:232\u2013245","journal-title":"Cancer Cell"},{"key":"997_CR9","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.leukres.2007.11.008","volume":"32","author":"Y Deguchi","year":"2008","unstructured":"Deguchi Y, Kimura S, Ashihara E, Niwa T, Hodohara K, Fujiyama Y et al (2008) Comparison of imatinib, dasatinib, nilotinib and INNO-406 in imatinib-resistant cell lines. Leuk Res 32:980\u2013983","journal-title":"Leuk Res"},{"key":"997_CR10","doi-asserted-by":"crossref","first-page":"5697","DOI":"10.1182\/blood-2011-07-367326","volume":"118","author":"FE Nicolini","year":"2011","unstructured":"Nicolini FE, Basak GW, Soverini S, Martinelli G, Mauro MJ, Muller MC et al (2011) Allogeneic stem cell transplantation for patients harboring T315I BCR-ABL mutated leukemias. Blood 118:5697\u20135700","journal-title":"Blood"},{"key":"997_CR11","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.3324\/haematol.2012.080234","volume":"98","author":"FE Nicolini","year":"2013","unstructured":"Nicolini FE, Ibrahim AR, Soverini S, Martinelli G, Muller MC, Hochhaus A et al (2013) The BCR-ABLT315I mutation compromises survival in chronic phase chronic myelogenous leukemia patients resistant to tyrosine kinase inhibitors, in a matched pair analysis. Haematologica 98:1510\u20131516","journal-title":"Haematologica"},{"key":"997_CR12","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1158\/0008-5472.CAN-03-3207","volume":"64","author":"T Stiff","year":"2004","unstructured":"Stiff T, O\u2019Driscoll M, Rief N, Iwabuchi K, Lobrich M, Jeggo PA (2004) ATM and DNA-PK function redundantly to phosphorylate H2AX after exposure to ionizing radiation. Cancer Res 64:2390\u20132396","journal-title":"Cancer Res"},{"key":"997_CR13","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/nature03442","volume":"434","author":"J Falck","year":"2005","unstructured":"Falck J, Coates J, Jackson SP (2005) Conserved modes of recruitment of ATM, ATR and DNA-PKcs to sites of DNA damage. Nature 434:605\u2013611","journal-title":"Nature"},{"key":"997_CR14","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1476-4598-7-61","volume":"7","author":"Y Liu","year":"2008","unstructured":"Liu Y, Parry JA, Chin A, Duensing S, Duensing A (2008) Soluble histone H2AX is induced by DNA replication stress and sensitizes cells to undergo apoptosis. Mol Cancer 7:61","journal-title":"Mol Cancer"},{"key":"997_CR15","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nature07849","volume":"458","author":"PJ Cook","year":"2009","unstructured":"Cook PJ, Ju BG, Telese F, Wang X, Glass CK, Rosenfeld MG (2009) Tyrosine dephosphorylation of H2AX modulates apoptosis and survival decisions. Nature 458:591\u2013596","journal-title":"Nature"},{"key":"997_CR16","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.molcel.2006.05.023","volume":"23","author":"C Lu","year":"2006","unstructured":"Lu C, Zhu F, Cho YY, Tang F, Zykova T, Ma WY et al (2006) Cell apoptosis: requirement of H2AX in DNA ladder formation, but not for the activation of caspase-3. Mol Cell 23:121\u2013132","journal-title":"Mol Cell"},{"key":"997_CR17","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1007\/s10495-013-0875-x","volume":"18","author":"C Lu","year":"2013","unstructured":"Lu C, Xiong M, Luo Y, Li J, Zhang Y, Dong Y et al (2013) Genome-wide transcriptional analysis of apoptosis-related genes and pathways regulated by H2AX in lung cancer A549 cells. Apoptosis 18:1039\u20131047","journal-title":"Apoptosis"},{"key":"997_CR18","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s00412-009-0234-4","volume":"118","author":"JS Dickey","year":"2009","unstructured":"Dickey JS, Redon CE, Nakamura AJ, Baird BJ, Sedelnikova OA, Bonner WM (2009) H2AX: functional roles and potential applications. Chromosoma 118:683\u2013692","journal-title":"Chromosoma"},{"key":"997_CR19","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/sj.leu.2403651","volume":"19","author":"SH Walsh","year":"2005","unstructured":"Walsh SH, Rosenquist R (2005) Absence of H2AX gene mutations in B-cell leukemias and lymphomas. Leukemia 19:464","journal-title":"Leukemia"},{"key":"997_CR20","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1158\/0008-5472.CAN-06-3497","volume":"67","author":"Y Liu","year":"2007","unstructured":"Liu Y, Tseng M, Perdreau SA, Rossi F, Antonescu C, Besmer P et al (2007) Histone H2AX is a mediator of gastrointestinal stromal tumor cell apoptosis following treatment with imatinib mesylate. Cancer Res 67:2685\u20132692","journal-title":"Cancer Res"},{"key":"997_CR21","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1111\/j.1349-7006.2009.01172.x","volume":"100","author":"A Nagamachi","year":"2009","unstructured":"Nagamachi A, Yamasaki N, Miyazaki K, Oda H, Miyazaki M, Honda Z et al (2009) Haploinsufficiency and acquired loss of Bcl11b and H2AX induces blast crisis of chronic myelogenous leukemia in a transgenic mouse model. Cancer Sci 100:1219\u20131226","journal-title":"Cancer Sci"},{"key":"997_CR22","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0092-8674(03)00566-X","volume":"114","author":"CH Bassing","year":"2003","unstructured":"Bassing CH, Suh H, Ferguson DO, Chua KF, Manis J, Eckersdorff M et al (2003) Histone H2AX: a dosage-dependent suppressor of oncogenic translocations and tumors. Cell 114:359\u2013370","journal-title":"Cell"},{"key":"997_CR23","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1096\/fj.07-101394","volume":"22","author":"A Puissant","year":"2008","unstructured":"Puissant A, Grosso S, Jacquel A, Belhacene N, Colosetti P, Cassuto JP et al (2008) Imatinib mesylate-resistant human chronic myelogenous leukemia cell lines exhibit high sensitivity to the phytoalexin resveratrol. FASEB J 22:1894\u20131904","journal-title":"FASEB J"},{"key":"997_CR24","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1016\/S0092-8674(04)00031-5","volume":"116","author":"P Li","year":"2004","unstructured":"Li P, Nijhawan D, Wang X (2004) Mitochondrial activation of apoptosis. Cell 116:S57\u2013S59","journal-title":"Cell"},{"key":"997_CR25","doi-asserted-by":"crossref","first-page":"4779","DOI":"10.1093\/emboj\/18.17.4779","volume":"18","author":"S Thomson","year":"1999","unstructured":"Thomson S, Clayton AL, Hazzalin CA, Rose S, Barratt MJ, Mahadevan LC (1999) The nucleosomal response associated with immediate-early gene induction is mediated via alternative MAP kinase cascades: MSK1 as a potential histone H3\/HMG-14 kinase. EMBO J 18:4779\u20134793","journal-title":"EMBO J"},{"key":"997_CR26","doi-asserted-by":"crossref","first-page":"9390","DOI":"10.1074\/jbc.M109.057745","volume":"285","author":"M Shimada","year":"2010","unstructured":"Shimada M, Nakadai T, Fukuda A, Hisatake K (2010) cAMP-response element-binding protein (CREB) controls MSK1-mediated phosphorylation of histone H3 at the c-fos promoter in vitro. J Biol Chem 285:9390\u20139401","journal-title":"J Biol Chem"},{"key":"997_CR27","doi-asserted-by":"crossref","first-page":"13269","DOI":"10.1074\/jbc.M112.402560","volume":"288","author":"Y Atsumi","year":"2013","unstructured":"Atsumi Y, Inase A, Osawa T, Sugihara E, Sakasai R, Fujimori H et al (2013) The Arf\/p53 protein module, which induces apoptosis, down-regulates histone H2AX to allow normal cells to survive in the presence of anti-cancer drugs. J Biol Chem 288:13269\u201313277","journal-title":"J Biol Chem"},{"key":"997_CR28","doi-asserted-by":"crossref","first-page":"6050","DOI":"10.1111\/j.1742-4658.2009.07329.x","volume":"276","author":"AS Gillings","year":"2009","unstructured":"Gillings AS, Balmanno K, Wiggins CM, Johnson M, Cook SJ (2009) Apoptosis and autophagy: BIM as a mediator of tumour cell death in response to oncogene-targeted therapeutics. FEBS J 276:6050\u20136062","journal-title":"FEBS J"},{"key":"997_CR29","doi-asserted-by":"crossref","first-page":"6172","DOI":"10.1128\/MCB.24.14.6172-6183.2004","volume":"24","author":"R Kuribara","year":"2004","unstructured":"Kuribara R, Honda H, Matsui H, Shinjyo T, Inukai T, Sugita K et al (2004) Roles of Bim in apoptosis of normal and Bcr-Abl-expressing hematopoietic progenitors. Mol Cell Biol 24:6172\u20136183","journal-title":"Mol Cell Biol"},{"key":"997_CR30","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1016\/j.leukres.2009.03.033","volume":"33","author":"HY Jia","year":"2009","unstructured":"Jia HY, Wu JX, Zhu XF, Chen JM, Yang SP, Yan HJ et al (2009) ZD6474 inhibits Src kinase leading to apoptosis of imatinib-resistant K562 cells. Leuk Res 33:1512\u20131519","journal-title":"Leuk Res"},{"key":"997_CR31","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nrm2308","volume":"9","author":"RJ Youle","year":"2008","unstructured":"Youle RJ, Strasser A (2008) The BCL-2 protein family: opposing activities that mediate cell death. Nat Rev Mol Cell Biol 9:47\u201359","journal-title":"Nat Rev Mol Cell Biol"},{"key":"997_CR32","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1369\/jhc.2008.951251","volume":"56","author":"E Bartova","year":"2008","unstructured":"Bartova E, Krejci J, Harnicarova A, Galiova G, Kozubek S (2008) Histone modifications and nuclear architecture: a review. J Histochem Cytochem 56:711\u2013721","journal-title":"J Histochem Cytochem"},{"key":"997_CR33","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/sj.cdd.4401180","volume":"10","author":"M Schuler","year":"2003","unstructured":"Schuler M, Maurer U, Goldstein JC, Breitenbucher F, Hoffarth S, Waterhouse NJ et al (2003) p53 triggers apoptosis in oncogene-expressing fibroblasts by the induction of Noxa and mitochondrial Bax translocation. Cell Death Differ 10:451\u2013460","journal-title":"Cell Death Differ"},{"key":"997_CR34","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/mrd.22268","volume":"81","author":"N Beaujean","year":"2014","unstructured":"Beaujean N (2014) Histone post-translational modifications in preimplantation mouse embryos and their role in nuclear architecture. Mol Reprod Dev 81:100\u2013112","journal-title":"Mol Reprod Dev"},{"key":"997_CR35","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1074\/mcp.M113.029025","volume":"13","author":"C Zhang","year":"2014","unstructured":"Zhang C, Gao S, Molascon AJ, Liu Y, Andrews PC (2014) Quantitative Proteomics Reveals Histone Modifications in Crosstalk with H3 Lysine 27 Methylation. Mol Cell Proteomics 13:749\u2013759","journal-title":"Mol Cell Proteomics"}],"container-title":["Apoptosis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-014-0997-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10495-014-0997-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-014-0997-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T14:41:33Z","timestamp":1559140893000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10495-014-0997-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,15]]},"references-count":35,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["997"],"URL":"https:\/\/doi.org\/10.1007\/s10495-014-0997-9","relation":{},"ISSN":["1360-8185","1573-675X"],"issn-type":[{"value":"1360-8185","type":"print"},{"value":"1573-675X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,15]]}}}